Skip to content
10-K

Annual Report

TELA Bio, Inc. TELA

0001558370-25-003460

← back to feed
Filed
Mar 21, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 14, 2025 39.55M sh
Long Term Debt FY 2024 · Dec 31, 2023 $40.52M
Cash And Equivalents FY 2024 · Dec 31, 2023 $46.73M
Current Liabilities FY 2024 · Dec 31, 2023 $16.97M
Total Liabilities FY 2024 · Dec 31, 2023 $59.17M
Current Assets FY 2024 · Dec 31, 2023 $71.73M
Total Assets FY 2024 · Dec 31, 2023 $78.05M
Shares Diluted FY 2024 · Dec 31, 2022 16.27M sh
Capex FY 2024 · Dec 31, 2022 $872K
Operating Cash Flow FY 2024 · Dec 31, 2022 −$40.75M
Eps Diluted FY 2024 · Dec 31, 2022 −$2.72
Eps Basic FY 2024 · Dec 31, 2022 −$2.72
Sga Expense FY 2024 · Dec 31, 2022 $13.86M
Rd Expense FY 2024 · Dec 31, 2022 $8.94M
Net Income FY 2024 · Dec 31, 2022 −$44.3M
Operating Income FY 2024 · Dec 31, 2022 −$39.01M
Gross Profit FY 2024 · Dec 31, 2022 $27.04M
Revenue FY 2024 · Dec 31, 2022 $41.42M
Stockholders Equity FY 2024 · Dec 31, 2021 $20.1M